Correspondence and offprint requests to: Stella Edström Halling; E-mail: stella.edstrom.halling@ki.se Abstract Background. There has been a lack of international consensus on the classification and the predictive value of the histopathology findings in IgA nephropathy (IgAN). Recently, the International IgA Nephropathy Network has developed the Oxford classification in which four histological variables with the most prognostic importance are identified (MEST score). Our objective was to validate these findings and to assess their predictive power in our cohort and to compare them to identified clinical predictors. Methods. Ninety-nine children with a follow-up time >5 years were included and investigated with clearances of inulin or iohexol for glomerular filtration rate (GFR), proteinuria and blood pressure at biopsy and during followup. Biopsies (90/99) were re-evaluated and scored according to the Oxford classification.
Results. Eighteen patients progressed to a poor outcome [end-stage renal disease (ESRD) or GFR reduction >50%].
In the univariate analysis, we found that mesangial hypercellullarity score >0.5, presence of endocapillary hypercellularity or tubular atrophy/interstitial fibrosis of >25% were each associated with a poor outcome, and also presence of cellular or fibrocellular crescents and of global glomerulosclerosis, but segmental glomerulosclerosis did not reach statistical significance. The clinical predictors of a poor outcome were a low GFR, a high mean arterial blood pressure and a high amount of albuminuria (log
Introduction
The natural history of IgA nephropathy (IgAN) shows wide variability in the clinical setting. Long-term studies of paediatric IgAN report different progression rates, with a 10-year renal survival of 87-93% and a 20-year renal survival of 73-89% [1] [2] [3] . Several clinical predictors of poor outcome have been discussed, such as age at diagnosis [4] , severe proteinuria, hypertension and impaired renal function at presentation [2, 5] . Biopsies show a wide range of different stages of pathology from nearly normal histology, apart from deposits of IgA in the glomeruli, to severe pathology findings with crescentic or sclerotic/necrotic lesions. There has been a lack of international consensus in the validation of previous histopathological classifications [6, 7] . In the new Oxford classification (Oxford MEST score), the International IgA Nephropathy Network has identified four histopathological lesions of independent prognostic importance; mesangial (M) and endocapillary (E) hypercellularity, segmental glomerulosclerosis (S), tubular atrophy and interstitial fibrosis (T). The results were analysed using a systematic approach in order to develop a reproducible classification which could predict clinical outcome [8, 9] . The Oxford classification score has been shown to be valid also in paediatric IgAN [10] . Our aim was to assess the predictability of these findings and clinical variables among our IgAN patients to improve the prognostic evaluation.
Materials and methods
Our clinic is one of two referral centres for children with kidney diseases in Sweden. We studied retrospectively and prospectively 99 consecutive children and adolescents (58 boys) with a follow-up period of >5 years up to 36 (mean 13 AE 8 years, n ¼ 92) or had reached end-stage renal disease (ESRD) earlier than after 5 years (n ¼ 7). Their mean age was 12 AE 3.6 years at the first investigation. Two patients died due to non-renal causes. Forty-seven patients (47%), 29 boys, were followed for >10 years and 19 patients (19%), 9 boys, for >20 years. The patients were investigated with clearances of inulin during water diuresis or plasma clearance of iohexol to determine glomerular filtration rate (GFR) [11] at time of biopsy and at 1, 3 and 5 years of follow-up and at the last visit. Fifty-nine healthy children aged 11.7 AE 3.6 years served as controls for GFR. Clinical baseline characteristics included weight, height, serum creatinine, proteinuria and blood pressure measurements adjusted for gender, age and height. Systolic and diastolic hypertension was defined as above the 95th percentile [12] . Proteinuria was measured as the ratio of urine albumin/creatinine (Ualb/c), defined as normoalbuminuric or microalbuminuric if Ualb/c was <25 mg/mmol, mild if the ratio was 25-200 mg/mmol, moderate if !200 to <400 mg/mmol and nephrotic if !400 mg/mmol. A renal biopsy was performed in all 99 children during 1974-2007. One-third of the cohort (31/99) was biopsied after the year 2000. Three of the late biopsied patients deteriorated to ESRD within half a year and they were included in the study. Ninety specimens were available for review. The biopsies were performed at a median of 1.6 [interquartile (IQ) range 0.5-4.2] years of disease duration and were examined by one pathologist (M.P.S.), who was blinded to patient outcome at the time of scoring. The biopsies were analysed based on 3 l Periodic acid Schiff-stained sections. There was a median of 16 (IQ range 10-23) glomeruli in each biopsy and no specimen had <5 glomeruli. The biopsy specimens were classified and standardized according to the Oxford classification [8] , in which the number of glomeruli was assessed and their mesangial hypercellullarity scored as 0.5 or >0.5, if more or less than half of the glomeruli showed hypercellullarity defined as >4 mesangial cells/mesangial area, endocapillary hypercellullarity (absent or present), segmental glomerulosclerosis (absent or present) and tubular atrophy/interstitial fibrosis (TAIF) (0 ¼ 0-25%, 1 ¼ 26-50% and 2 ¼ >50%). The percentage of glomeruli with cellular and fibrocellular crescents and global glomerulosclerosis (GGS) was calculated and was classified as absent or present.
Treatment was recorded in three different groups: (i) renin angiotensin aldosterone system (RAAS) blockade, indicating treatment with ACEis (angiotensin-converting enzyme inhibitors) or ARBs (angiotensin receptor blockers) or both, n ¼ 24, (ii) immunosuppression with corticosteroids in combination with RAAS blockade, n ¼ 4 and (iii) immunosuppression with corticosteroids and cyclophosphamide in combination with RAAS blockade, n ¼ 7. Seven patients had received treatment with RAAS blockade prior to biopsy at a median of 0.13 years from onset and two of these patients had also received corticosteroids prior to biopsy. Treatment during followup was given on clinical indications and did not follow any protocol.
The primary outcome was defined as poor if GFR:last was reduced >50% from GFR:bio or if the patient had reached ESRD.
Statistical analysis
Statistica 9.0 (Statsoft Inc., Tulsa, OK) was used for all statistical analyses. Variables were expressed as the mean and SD for continuous and approximately normally distributed variables and the median and IQ range for skewed data. The Ualb/c was log-(e)-transformed to obtain approximately normally distributed data. To test for differences between groups, Student's t-test was used for approximately normally distributed data and the MannWhitney U-test for data with a skewed distribution. The chi-square test was used to test for differences between proportions, i.e. categorical variables. The Spearman correlation coefficient was used to explore the relationship between the presence of each histological lesion and treatment and between one histological and one clinical variable and the Pearson's correlation coefficient was used for the relationship between two histological lesions ( Table 4 ). The Kaplan-Meier curve was used to illustrate univariate differences between groups of clinical and pathological variables, with respect to time to poor outcome. Cox proportional hazard regression was used to estimate the hazard ratio (HR) between groups (levels) within each factor, by univariate comparisons. Estimates were presented with their corresponding 95% confidence intervals (CIs). Multiple hazard regression was used to estimate a model including a combination of the independent factors of interest and was also used to explore which factors were overall the most important discriminators for time to poor outcome. All tests were two-sided and a P-value <0.05 was considered as statistically significant.
Results

Clinical predictors
GFR at the time of biopsy (GFR:bio) was 100 AE 31 mL/min/ 1.73m 2 , significantly lower than that of controls, GFR 117 AE 10 mL/min/1.73m 2 , (P < 0.001). Seventy-two patients had a GFR:bio >90 mL/min/1.73m 2 (chronic kidney disease, CKD Eighteen patients progressed to poor outcome; 15 (12 boys) developed ESRD after a median of 6 (0.1-14.8) years from onset and an additional 3 patients reduced their GFR by 50% without progressing to ESRD within the follow-up period. Four patients, all with risk factors (hypertension and/or reduced GFR and/or nephrotic proteinuria at biopsy), had a very rapid deterioration and developed ESRD within 6 months from onset. The annual median rate of renal function decline (GFR:slope) was À0.8 (IQR À3.1 to 1.2) mL/min/ 1.73m 2 /year if the four patients with very rapid deterioration were excluded (GFR:slope >50 mL/min/1.73m 2 /year). Table 1 shows the differences in clinical variables between patients with good and poor (n ¼ 18) outcomes. Patients with a poor outcome had lower GFR, higher mean arterial blood pressure (MAP) and higher log Ualb/c at the time of biopsy compared to those with a good outcome. GFR remained reduced and proteinuria (log Ualb/c) remained increased during follow-up in the poor versus good outcome group, although the follow-up time was longer in the good outcome group. The proportion of males with poor outcome did not differ from that of females 13/58 (22%) versus 5/41 (12%), P ¼ 0.19. The HRs of the predictors verified in the Cox regression univariate analysis are shown in Table 2 . MAP was identified as a predictor only at the time of biopsy (HR 1.1, CI 1.05-1.1; P < 0.001) and not during follow-up.
The 10-year actuarial renal survival in this study was 86%. Figure 1a -d shows the renal survival with regard to the identified clinical predictors at biopsy. We found that nephrotic proteinuria as well as moderate proteinuria, reduced GFR:bio and hypertension at biopsy were all individual factors of poor renal survival compared with patients without these risk factors. The amount of proteinuria at biopsy increased the risk: Ualb/c >200: HR 23, P < 0.001, n ¼ 17 and Ualb/c >400: HR 27, P < 0.001, n ¼ 12 compared to the reference Ualb/c <200 mg/mmol. Proteinuria at follow-up was also shown to be a powerful predictor; renal survival differed between the patients with log Ualb/c >200 at 1 year and those with log Ualb/c <200 (log rank <0.001).
Histopathological predictors
Univariate analysis. Ninety of the 99 biopsies were available for re-analysis based on the new classification. Table 3 shows the predictive power of the different histological lesions in the Cox regression analysis. A mesangial hypercellularity score >0.5 (M1), the presence of endocapillary hypercellularity (E1) and TA/IF of !26% (T1-2) as well as presence of cellular and fibrocellular crescents (C1) and of GGS1 were all individual predictors of a poor prognosis in the univariate analysis in which M1, E1, T1-2 and C1 were found to have the highest HRs. S1 was not found to be significantly predictive in the univariate analysis (P ¼ 0.10).
Figure 2a-f shows the differences in renal survival for presence and absence of the histological findings and Figure 3 illustrates the distribution of the frequencies in each histology lesion. In our cohort, 30% of the patients had biopsies showing M1, 10% E1, 23% S1, 16% T1-2, 17% C1 and 29% GGS. The mesangial hypercellularity score was mean 0.47 AE 0.59. Within the group of patients with fibrocellular/cellular crescents, the mean percentage was 4.5 AE 13.4 and the corresponding figures for segmental glomerulosclerosis% was 3.1 AE 7.5 and for GGS% 6.3 AE 16.3.
Multivariate analysis. Two multivariate models were constructed including one single histological lesion in combination with proteinuria at biopsy ( Table 3 , Model A) and proteinuria at 1-year follow-up (Model B). We found that E1 was associated with a significant risk of a poor outcome in both models, but for all other histological lesions except S1, the risk of a poor prognosis was significant only in Model B. When two histological variables were included, without any clinical variable, the combination of M1/E1 gave the highest risk and when two histological variables were added in Model A, the combination M1/T1-2 showed equally high risk as the combination E1/T1-2. In Model B, the combination of E1/T1-2 showed the highest risk. In the multivariate model, no combination with S1 added any predictive information.
Correlations between different histological variables. We found positive correlations between several histological lesions shown in Table 4 . The strongest correlation of all histological combinations was found between TA/IF and GGS (r ¼ 0.83). TA/IF correlated to all other histology lesions. We also found strong correlations between M and E and between C and E. The strongest correlations among clinical variables with regard to histology were found between log Ualb/c at biopsy and M1 and log Ualb/c at biopsy and C1 (r ¼ 0.47, respectively). GFR:bio correlated inversely with all histological variables (data not shown).
Associations between clinical and histologic variables. Table 5 shows the association between the histological lesions at the time of biopsy and at the last visit. All histological lesions (M1, E1, S1, T1-2, C1 and GGS1) were associated individually with a reduced GFR:bio and a high log Ualb/c at the time of biopsy. At the last visit, all histological lesions except S1 were associated with reduced GFR:last and all except C1 also with a high log Ualb/c last.
The annual GFR reduction (GFR slope) was more prominent among patients with T1-2 findings than among patients without this lesion (P ¼ 0.016), but no significant difference in GFR slope was found when comparing presence (M1, E1, S1, C1, GGS1) with absence (M0, E0, S0, C0, GGS0) of any other histologic lesion.
Treatment
Thirty-four per cent of the patients had received treatment from Groups 1-3 (see Materials and methods section). Only the severe cases were treated. Patients with nephrotic proteinuria and/or hypertension at biopsy occurred more frequently among treated than non-treated patients (P ¼ 0.002 and P ¼ 0.02, respectively). In the different histology groups, we found associations to treatment among patients with T1-2 (r ¼ 0.32, Spearman correlation) and to E1 and C1 (r ¼ 0.22 and r ¼ 0.26, respectively). Immunosuppressive drugs (IS) were more common among patients with crescents than among those without (P < 0.001). Treatment with ACEi/ARB was given more frequently to patients with TA/IF than to those without this lesion (P ¼ 0.007). The GFR slope did not differ significantly before (À0.8 AE 2.6 mL/min/1.73m When treatment (IS and ACEi/ARB, respectively) was added as a clinical variable in the multivariate analysis the prognostic significance of the histology variables M1, E1, T1-2, C1 and GGS1 still remained significant.
Discussion
The two main objectives of this study were to identify the clinical and histopathologic predictors of a poor prognosis in IgAN and to compare their prognostic power. Many authors have emphasized the predictive value of the clinical variables at onset and during follow-up [1, 2] , but the controversial issue is whether the histological findings have an a GFR, mL/min/1.73m 2 , log Ualb/c ¼ log urine albumin/urine creatinine ratio, mg/mmol. ***P < 0.001, **P < 0.01, *P < 0.05. individual impact on the prognostic assessment, independently of clinical variables [8, 9, 13, 14] . In this study, GFR:bio, MAP and log Ualb/c at biopsy and GFR and log Ualb/c at follow-up were found to be clinical predictors of a poor outcome (Table 2 and Figure 1) , with log Ualb/c at biopsy being the stronger predictor. Our findings that nephrotic as well as moderate proteinuria and hypertension at the time of biopsy and proteinuria at follow-up were predictive factors of a poor outcome (Table 2, Figure 1 ) are in agreement with several other authors [1, 2, [13] [14] [15] [16] [17] [18] [19] . We also found a low GFR at biopsy and at follow-up indicating an unfavourable prognosis in the univariate g Fig. 2 . (a-f) Renal survival in relation to histological variables M<0.5 ¼ mesangial hypercellullarity score 0.5 (M0), M>0.5 ¼ mesangial hypercellullarity score >0.5 (M1); E0 ¼ no endocapillary hypercellullarity, E1 ¼ endocapillary hypercellullarity present; S0 ¼ no segmental glomerulosclerosis, S1 ¼ segmental glomerulosclerosis present; T<25%
analysis but not in the multivariate analysis (Models A and B). In studies reviewed by Coppo and D'Amico [1, 2] , impaired GFR at diagnosis was not found to indicate a poor long-term prognosis among children. Our results show that each one of the histologic findings M1, E1, T1-2, C1 and GGS1 was associated with a poor prognosis, but we did not find S1 to be of statistical prognostic significance (Table 3, Figure 2) . However, the low number of patients might explain why we did not reach significance with regard to S.
Taking into account the relatively small sample size, endocapillary proliferation (E) was shown to be a strong predictor in this study, although we found a weak association to treatment. Oxford classification study and other studies have shown that the amount of E is more frequent, and the amount of T is less frequent among paediatric patients compared to adults [8, 10, 20] . In the Oxford classification study, E was not significantly predictive of a poor prognosis, and the authors show a strong association to treatment and therefore E was excluded in their multivariate model.
In our study, special attention was given to patients with cellular or fibrocellular crescents (C) as they had a high predictive value (HR 6.6, CI 2.1-20.5) in the univariate analysis, although it did not maintain its significance in the multivariate analysis (Model A). This observation is shared with authors of several other studies reviewed by D'Amico [2] . Cellular or fibrocellular crescents were not predictive in the Oxford classification study, due to a low prevalence. In our study, a higher percentage of patients with C were treated with immunosuppression and/or ACEi than patients without this lesion, but treatment did not seem to prevent a poor outcome, which might be due to the interactive effect of co-existing chronic lesions in the biopsy specimens with cellular or fibrocellular crescents. We have discussed our experiences of treatment in the most severe cases of IgAN and their effect on outcome in a previous paper [21] .
TA/IF >26% was found in 16% of the cases and had high prognostic importance in this study (HR 7.3, CI 2.7-20.2). In a previous paper from our group, we showed that the segmental glomerulosclerosis and tubulointerstitial damage were associated with a low GFR [22] . TA/IF has been shown to be a strong independent predictor in several studies reviewed by D'Amico [2] , and in a recent paper [23] , the authors showed that even a small amount of IF increases the risk of ESRD. As in the Oxford study, we identified a correlation between GGS and TA/IF (r ¼ 0.83).
When comparing our results with those of the international study, certain differences in the design must be observed. In the Oxford classification study, the patients with initial GFR <30 mL/min/1.73m 2 and a urine albumin excretion <0.5 g/24 h/1.73m 2 in children were excluded, and those with a follow-up of more than a year were included. When we excluded the first pre-requisite, our results for renal survival still remained significant for all histological lesions except crescents (log rank 0.066). Moreover, we did not exclude patients with urine albumine excretion <0.5 g/ 24 h/1.73m 2 and we also had different inclusion criteria regarding disease duration. We selected patients who have had the disease for >5 years (except for four patients with very rapid deterioration reaching ESRD within 5 years), in order to enhance the opportunity of finding independent prognostic factors of a poor prognosis. In contrast, the original study included cases after 12 months of disease duration, to minimize the impact of the most acute and rapidly progressive cases. In our study of 90 children, the frequency of patients reaching the end point (GFR reduction >50% or ESRD) was lower than in the Oxford study of 209 adults and 59 children (18 versus 35%, respectively), which might be due to the different selections of included patients. Our Models A and B, including one clinical and one histological variable, differ from those in the Oxford classification study in which three clinical and three histological variables were included. When we replaced log Ualb/c with GFR bio/GFR 1 year in Models A and B, we did not obtain any further prognostic information. Due to the low number of events (n ¼ 18), we could not expand our models.
Our actuarial 10-year renal survival of 86% is in the lower range of results reported from other centres [1] [2] [3] [4] and poorer than in the Japanese studies (96.4%) [24] . These results might reflect different indications for renal biopsy in Europe, in the USA and in Japan [3] and also the different traditions of treatment over time and between the countries. Our 10-year renal survival could also be explained by the fact that our cohort shows a high proportion of advanced disease, due to referral patients.
In summary, all histological variables except S were each highly discriminative of a poor prognosis in the univariate analysis. However, in the multivariate analysis, we found that the discriminative ability was reduced when histology was combined with proteinuria at biopsy ( Table  3 , Model A), whereas the ability was more pronounced when histology was combined with proteinuria at 1-year follow-up (Model B). The observation might be due to the selection of patients with a more severe disease in Model B and the smaller sample size.
The low discriminative power of histological variables in our Model A is due to the impact of albuminuria at biopsy, as only two variables can be included in the multivariate model. Although a limited number of patients with a poor outcome in our study could lead to conclusions in the analysis of the subgroups as underpowered, we still reached some noteworthy results. The strengths of this study are the total sample size and the long follow-up time (mean 13 years with 50% of the patients with follow-up time of >10 years) and the accuracy of the renal function investigations with GFR being measured by clearance studies. The limitation is that the study cohort mainly consists of referral patients which might overestimate the poor prognosis.
In conclusion, we found that the Oxford classification score is a valuable tool for prognostic purposes. We also found in our paediatric population that the presence of cellular/fibrocellular crescents was of prognostic significance as well as albuminuria at biopsy and during follow-up. , log Ualb/c ¼ log urine albumin/urine creatinine ratio, mg/mmol, n.s. ¼ not significant. Histologic abbreviations as in Table 3 .
